Cargando…
Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation
Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aeros...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538331/ https://www.ncbi.nlm.nih.gov/pubmed/36168221 http://dx.doi.org/10.1111/ina.13115 |
_version_ | 1784803338803478528 |
---|---|
author | Ruetalo, Natalia Berger, Simon Niessner, Jennifer Schindler, Michael |
author_facet | Ruetalo, Natalia Berger, Simon Niessner, Jennifer Schindler, Michael |
author_sort | Ruetalo, Natalia |
collection | PubMed |
description | Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aerosolized SARS‐CoV‐2 and exposed the aerosols to a defined UV‐C dose. Our results demonstrate that the exposure of aerosolized SARS‐CoV‐2 with a low average dose in the order of 0.42–0.51 mJ/cm(2) UV‐C at 254 nm resulted in more than 99.9% reduction in viral titers. Altogether, UV‐C‐based decontamination of aerosols seems highly effective to achieve a significant reduction in SARS‐CoV‐2 infectivity. |
format | Online Article Text |
id | pubmed-9538331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95383312022-10-11 Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation Ruetalo, Natalia Berger, Simon Niessner, Jennifer Schindler, Michael Indoor Air Original Articles Surface residing SARS‐CoV‐2 is efficiently inactivated by UV‐C irradiation. This raises the question whether UV‐C‐based technologies are also suitable to decontaminate SARS‐CoV‐2‐ containing aerosols and which doses are needed to achieve inactivation. Here, we designed a test bench to generate aerosolized SARS‐CoV‐2 and exposed the aerosols to a defined UV‐C dose. Our results demonstrate that the exposure of aerosolized SARS‐CoV‐2 with a low average dose in the order of 0.42–0.51 mJ/cm(2) UV‐C at 254 nm resulted in more than 99.9% reduction in viral titers. Altogether, UV‐C‐based decontamination of aerosols seems highly effective to achieve a significant reduction in SARS‐CoV‐2 infectivity. John Wiley and Sons Inc. 2022-09-21 2022-09 /pmc/articles/PMC9538331/ /pubmed/36168221 http://dx.doi.org/10.1111/ina.13115 Text en © 2022 The Authors. Indoor Air published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Ruetalo, Natalia Berger, Simon Niessner, Jennifer Schindler, Michael Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title | Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title_full | Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title_fullStr | Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title_full_unstemmed | Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title_short | Inactivation of aerosolized SARS‐CoV‐2 by 254 nm UV‐C irradiation |
title_sort | inactivation of aerosolized sars‐cov‐2 by 254 nm uv‐c irradiation |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538331/ https://www.ncbi.nlm.nih.gov/pubmed/36168221 http://dx.doi.org/10.1111/ina.13115 |
work_keys_str_mv | AT ruetalonatalia inactivationofaerosolizedsarscov2by254nmuvcirradiation AT bergersimon inactivationofaerosolizedsarscov2by254nmuvcirradiation AT niessnerjennifer inactivationofaerosolizedsarscov2by254nmuvcirradiation AT schindlermichael inactivationofaerosolizedsarscov2by254nmuvcirradiation |